Development of OX40 agonists for canine cancer immunotherapy

Recent breakthroughs in cancer immunotherapy have provided unprecedented clinical benefits to human cancer patients. Cancer is also one of the most common causes of death in pet dogs. Thus, canine-specific immune therapies targeting similar signaling pathways can provide better treatment options for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Damien, Haynes, Chloe, Marable, Jonathan, Pundkar, Chetan, Nance, Rebecca L., Bedi, Deepa, Agarwal, Payal, Suryawanshi, Amol S., Mishra, Amarjit, Smith, Bruce F., Sandey, Maninder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547195/
https://www.ncbi.nlm.nih.gov/pubmed/36217551
http://dx.doi.org/10.1016/j.isci.2022.105158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547195/
https://www.ncbi.nlm.nih.gov/pubmed/36217551
http://dx.doi.org/10.1016/j.isci.2022.105158

Ejemplares similares